With a market cap of $23.3 billion, Labcorp Holdings Inc. (LH) is a global life sciences and healthcare company. The North ...

LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds ...

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...

A healthcare company is preparing to pay $35,000,000 to settle a class action lawsuit over a cybersecurity incident that ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

BURLINGTON, N.C., June 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second ...

North Carolina-based LabCorp Diagnostics, one of the largest clinical laboratories in the U.S., was forced to shut down its network on Sunday after officials detected suspicious activity, according to ...

Collaboration leverages Olaris' scientific leadership in transplant diagnostics and Labcorp's scientific expertise and national scale to advance post-transplant monitoring. FRAMINGHAM, Mass.

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company deeply integrated in guiding patient care, has launched Insight Analytics™ reports that support provider ...